Getting latest data loading
Home / Blog / blog / Keeping an eye on the trading prize

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Keeping an eye on the trading prize

Corporate reporting season is in full swing on both sides of the Atlantic. Traders are eager to benefit from potentially attractive share price moves. Often, however, the share price moves seen around results require some deciphering.

What constitutes “good results” for the share price? Why would a share price react negatively even after positive headlines?

Let’s assume a UK 100 company says it grew revenues by 50% and doubled its profits. You’d expect the shares to rise, but there are a few reasons why they might still fall.

Profits growth is healthy for any company. As a new shareholder, however, you can’t buy into past growth. You can only buy into a company’s future prospects.

Profits growth is an indication of track record, but no guarantee of future returns. As a result, the profits outlook is more important than past performance for the share price. Lesson number 1: it’s all about the future, not the past.

Hence companies typically offer revenue/profits guidance for the current or next reporting year. Markets will pay close attention to whether this suggests optimism about continued growth, or concerns about stagnation, or worse, a slowdown.

One way to keep shareholders happy is to make sure that profits keep growing faster than revenues. At least meeting, if not beating, guidance. Lesson number 2: results only matter in relation to market expectations. Profits +100% is great, but when consensus was looking for 150%, it is still a glaring miss. To make matters worse, less profits means a lower base from which to grow.

The future outlookWhy does consensus matter? Because expectations for revenues, profits and cash flow underpin the perceived valuation of shares. If investors no longer expect a company to make as much profit in the future, why would the shares be worth the same today as they were yesterday based on the updated numbers?

The spin of headlines can be overwhelming. Especially as companies tend to hide disappointing results behind impressive headlines. Hence Accendo Markets cuts through the jargon, so you can make confident trading decisions.

Accendo scours the markets daily for attractive trading opportunities among companies scheduled to report. From UK 100 household brands to up-and-coming AIM growth unicorns, nothing escapes our watchful eye.

Are you prepared for major companies reporting latest results next week? Some of the unmissable big names next week include oil supermajor BP, pharma giant GlaxoSmithKline and British Airways owner IAG.

Take a look at our easily digestable Week in Advance for a full overview of next week’s action. Do you see a potential results play trade there?

Finally, for easy access to Accendo’s daily market research and experienced brokers, click here for our research Gold Pass.

Josh Phipps, Trader, 1 February 2019

 

« Back to Category

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Prepared by Michael van Dulken, Head of Research

Comments are closed.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.